ACE and autoimmune disease: Seven percent of the patients were receiving immunosuppressive medications, such as steroids, for associated autoimmune diseases, 10.6% were taking RAAS blockers including angiotensin converting enzyme inhibitors (ACEis) and angiotensin receptor blockers (ARBs) for blood pressure control.